Jayson Bedford
Stock Analyst at Raymond James
(3.89)
# 736
Out of 4,502 analysts
199
Total ratings
55.73%
Success rate
7.33%
Average return
Main Sectors:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN AxoGen | Initiates: Outperform | $13 | $9.56 | +36.05% | 1 | Jul 1, 2024 | |
| ICUI ICU Medical | Upgrades: Outperform | $135 | $126.93 | +6.36% | 10 | Jun 17, 2024 | |
| PODD Insulet | Maintains: Outperform | $218 → $213 | $197.26 | +7.98% | 14 | May 10, 2024 | |
| DXCM DexCom | Maintains: Strong Buy | $151 → $160 | $110.17 | +45.23% | 20 | Apr 26, 2024 | |
| BSX Boston Scientific | Maintains: Strong Buy | $73 → $85 | $76.02 | +11.81% | 15 | Apr 25, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $84 → $89 | $87.01 | +2.29% | 16 | Jan 30, 2024 | |
| ABT Abbott Laboratories | Maintains: Outperform | $124 → $127 | $106.82 | +18.90% | 21 | Jan 25, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $372 → $435 | $450.00 | -3.33% | 6 | Jan 25, 2024 | |
| ANGO AngioDynamics | Maintains: Outperform | $12 → $10 | $7.45 | +34.23% | 8 | Jan 9, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $133 → $137 | $112.03 | +22.29% | 4 | Jan 3, 2024 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $172 → $175 | $159.63 | +9.63% | 16 | Jan 3, 2024 | |
| BDX Becton, Dickinson and Company | Maintains: Outperform | $269 → $275 | $235.67 | +16.69% | 2 | Jan 3, 2024 | |
| TFX Teleflex | Maintains: Outperform | $227 → $271 | $226.81 | +19.48% | 12 | Dec 20, 2023 | |
| BWAY BrainsWay | Downgrades: Market Perform | n/a | $7.50 | - | 7 | Nov 16, 2023 | |
| MASI Masimo | Downgrades: Market Perform | n/a | $110.89 | - | 4 | Nov 8, 2023 | |
| TNDM Tandem Diabetes Care | Downgrades: Market Perform | n/a | $41.87 | - | 9 | Apr 24, 2023 | |
| EW Edwards Lifesciences | Downgrades: Market Perform | n/a | $63.53 | - | 13 | Feb 6, 2023 | |
| BAX Baxter International | Downgrades: Market Perform | n/a | $35.59 | - | 6 | Jan 5, 2023 | |
| MDT Medtronic | Downgrades: Market Perform | n/a | $80.21 | - | 8 | Aug 24, 2022 | |
| SENS Senseonics Holdings | Downgrades: Underperform | n/a | $0.47 | - | 2 | Mar 5, 2021 | |
| HOLX Hologic | Upgrades: Outperform | n/a | $78.56 | - | 1 | Jun 3, 2020 | |
| BEAT HeartBeam | Maintains: Outperform | n/a | $2.71 | - | 2 | Oct 31, 2018 | |
| IART Integra LifeSciences Holdings | Downgrades: Market Perform | n/a | $32.26 | - | 2 | Jan 2, 2018 |
AxoGen
Jul 1, 2024
Initiates: Outperform
Price Target: $13
Current: $9.56
Upside: +36.05%
ICU Medical
Jun 17, 2024
Upgrades: Outperform
Price Target: $135
Current: $126.93
Upside: +6.36%
Insulet
May 10, 2024
Maintains: Outperform
Price Target: $218 → $213
Current: $197.26
Upside: +7.98%
DexCom
Apr 26, 2024
Maintains: Strong Buy
Price Target: $151 → $160
Current: $110.17
Upside: +45.23%
Boston Scientific
Apr 25, 2024
Maintains: Strong Buy
Price Target: $73 → $85
Current: $76.02
Upside: +11.81%
Merit Medical Systems
Jan 30, 2024
Maintains: Outperform
Price Target: $84 → $89
Current: $87.01
Upside: +2.29%
Abbott Laboratories
Jan 25, 2024
Maintains: Outperform
Price Target: $124 → $127
Current: $106.82
Upside: +18.90%
Intuitive Surgical
Jan 25, 2024
Maintains: Outperform
Price Target: $372 → $435
Current: $450.00
Upside: -3.33%
AngioDynamics
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $7.45
Upside: +34.23%
Zimmer Biomet Holdings
Jan 3, 2024
Maintains: Outperform
Price Target: $133 → $137
Current: $112.03
Upside: +22.29%
Johnson & Johnson
Jan 3, 2024
Maintains: Outperform
Price Target: $172 → $175
Current: $159.63
Upside: +9.63%
Becton, Dickinson and Company
Jan 3, 2024
Maintains: Outperform
Price Target: $269 → $275
Current: $235.67
Upside: +16.69%
Teleflex
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $226.81
Upside: +19.48%
BrainsWay
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.50
Upside: -
Masimo
Nov 8, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $110.89
Upside: -
Tandem Diabetes Care
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $41.87
Upside: -
Edwards Lifesciences
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $63.53
Upside: -
Baxter International
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $35.59
Upside: -
Medtronic
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $80.21
Upside: -
Senseonics Holdings
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.47
Upside: -
Hologic
Jun 3, 2020
Upgrades: Outperform
Price Target: n/a
Current: $78.56
Upside: -
HeartBeam
Oct 31, 2018
Maintains: Outperform
Price Target: n/a
Current: $2.71
Upside: -
Integra LifeSciences Holdings
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $32.26
Upside: -